4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-044445
Pres and CEO gave up 4,437 shares (to pay taxes)
- Pres and CEO acquired 15,575 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Manion Douglas J. · Pres and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-01 | Exercise or conversion : show line 1 in the form | +15,575 | 28,375 | D | ||
| 2023-08-01 | Shares withheld for taxes : show line 2 in the form | −4,437 | $9.81 | $43,527 | 23,938 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −15,575 | 46,725 | D |
Loading xslF345X05/doc4.xml…